Last update 08 May 2025

CMV pp65 x EphA2 x survivin

Basic Info

Related Targets
CMV pp65EphA2survivin

Related

1
Drugs associated with CMV pp65 x EphA2 x survivin
P30-EPS vaccine(Duke University)
Target
CMV pp65 x EphA2 x survivin
Mechanism
CMV pp65 modulators [+3]
Active Org.
National Cancer InstituteNational Cancer Institute
Originator Org.
Duke UniversityDuke University
Active Indication
Glioblastoma Multiforme
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with CMV pp65 x EphA2 x survivin
NCT05283109
/ Active, not recruitingPhase 1IIT
ETAPA I: Evaluation of Tumor Associated P30-Peptide Antigen I; A Pilot Trial of Peptide-based Tumor Associated Antigen Vaccines in Newly Diagnosed, Unmethylated, and Untreated Glioblastoma (GBM)
100 Clinical Results associated with CMV pp65 x EphA2 x survivin
Login to view more data
100 Translational Medicine associated with CMV pp65 x EphA2 x survivin
Login to view more data
0 Patents (Medical) associated with CMV pp65 x EphA2 x survivin
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free